Jamie L. Reynoso, CEO, Medicare Advantage at CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV), sold 4,914 shares at $3.09 ($15K) on 2025-09-17, disclosed to the SEC on 2025-09-19.
Scheduled sale ($15k) by CEO, Medicare Advantage under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CLOV | SELL | 2026-09-18 | $9K | — | Filing → |
| CLOV | SELL | 2026-09-15 | $44K | — | Filing → |
| CLOV | SELL | 2026-07-17 | $22K | — | Filing → |